Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Anticoagulant sales for STEMI (ST-elevation myocardial infarction) are likely to double over the next decade,

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Decision Resources.Sales of Anticoagulants for the Treatment of St-Elevation Myocardial Infarction Will Double Over the Next 10 Years. Media Release: 22 Sep 2008. Available from: URL: http://www.decisionresources.com

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Anticoagulant sales for STEMI (ST-elevation myocardial infarction) are likely to double over the next decade,. Pharmacoecon. Outcomes News 563, 10 (2008). https://doi.org/10.2165/00151234-200805630-00023

    Download citation

    Keywords

    • Public Health
    • Sodium
    • Myocardial Infarction
    • Heparin
    • Health Outcome